Clinical Pearl · Cardio-Oncology
Cardio-Oncology Is About Preserving Cancer Therapy
The goal is not simply to identify cardiotoxicity, but to protect cardiovascular health while helping patients remain on effective cancer treatment whenever safely possible.
Baseline risk stratification and surveillance imaging allow earlier intervention before symptomatic dysfunction develops.
Cardioprotective therapy often permits continuation of oncologic treatment rather than premature discontinuation.
Shared decision-making with oncology, framed around overall prognosis and goals, produces better outcomes than unilateral clearance decisions.
Important notice
This content is for educational purposes only and is not medical advice for any individual patient. Patients should discuss diagnosis and treatment decisions with their own physician, or request a clinical consultation.